Pulmonary manifestations of systemic lupus erythematosus (SLE) are wide-ranging and
debilitating in nature. Previous studies suggest that anywhere between 20 and 90% of …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Background Connective tissue disease associated interstitial lung disease (CTD-ILD) is
associated with decreased quality of life and high mortality risk. Outcome and treatment …

Background There are chronic forms of hypersensitivity pneumonitis (cHP) that can progress
to pulmonary fibrosis. There is no recommended treatment for patients whose respiratory …

Abstract Purpose of Review This review aims to collate current evidence on the screening,
diagnosis, and treatment of various connective tissue disease (CTD)–associated interstitial …

Aim To investigate the potential therapeutic efficacy of iguratimod (IGU) on bleomycin (BLM)‐
induced pulmonary fibrosis in mice. Methods A total of 75 C57BL/6 mice were randomly and …

Objective This retrospective clinical study aimed to examine the similarities and differences
between connective tissue disease–associated interstitial lung disease (CTD-ILD) and …

Biomarkers to stratify the complex and heterogeneous phenotypes of Sjogren's syndrome
(SS) are needed. We aimed to validate the prevalence of anti-aquaporin 5 (AQP5) IgG in a …

Introduction The effectiveness of CD20 targeting in connective tissue diseases (CTD) with
lung involvement is controversial. This paper aims to review the current evidence about …

Objectives: Describe the epidemiology of undifferentiated connective tissue disease.
Summarize the pathophysiology of undifferentiated connective tissue disease. Explain the …